How Saudi Arabia is developing as a Middle East hub for clinical trials
Saudi Arabia is emerging as a major growth market for clinical trials in the Middle East, underpinned by strong funding and rapidly developing infrastructure. Vision 2030 reforms and specialised clinical trial logistics are coming together to enable complex, multicentre studies across the Kingdom.
